Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LITB
2601
LightInTheBox
LITB
$56.7M
| $850K | ﹤0.01% |
50,433
+1,066
| +2% | +$18.8K |
|
2602
American Financial Group
AFG
$12B
| $849K | ﹤0.01% |
+8,900
| New | +$816K |
|
|
ONVI
2603
DELISTED
Onvia, Inc.
ONVI
| $848K | ﹤0.01% |
192,800
+400
| +0.2% | +$1.77K |
|
|
QCP
2604
DELISTED
Quality Care Properties, Inc.
QCP
| $844K | ﹤0.01% |
+44,757
| New | +$795K |
|
2605
Larimar Therapeutics
LRMR
$454M
| $840K | ﹤0.01% |
+15,017
| New | +$746K |
|
|
DVD
2606
DELISTED
Dover Motorsports
DVD
| $828K | ﹤0.01% |
376,400
+1,200
| +0.3% | +$2.71K |
|
2607
Ocular Therapeutix
OCUL
$2.25B
| $825K | ﹤0.01% |
88,900
-56,200
| -39% | -$468K |
|
|
WPT
2608
DELISTED
World Point Terminals, LP
WPT
| $825K | ﹤0.01% |
50,682
-21,372
| -30% | -$358K |
|
|
HDP
2609
DELISTED
Hortonworks, Inc.
HDP
| $822K | ﹤0.01% |
+83,800
| New | +$810K |
|
2610
Geron
GERN
$1.01B
| $820K | ﹤0.01% |
+361,147
| New | +$770K |
|
|
GBL
2611
DELISTED
GAMCO Investors, Inc.
GBL
| $820K | ﹤0.01% |
27,700
-29,700
| -52% | -$894K |
|
2612
Companhia Siderúrgica Nacional
SID
$1.15B
| $819K | ﹤0.01% |
280,600
-741,900
| -73% | -$2.7M |
|
2613
Ultralife
ULBI
$120M
| $818K | ﹤0.01% |
150,100
+24,700
| +20% | +$134K |
|
|
CTO
2614
CTO Realty Growth
CTO
$819M
| $817K | ﹤0.01% |
56,218
+2,063
| +4% | +$30.1K |
|
|
FOE
2615
DELISTED
Ferro Corporation
FOE
| $817K | ﹤0.01% |
53,800
+28,700
| +114% | +$411K |
|
2616
Apyx Medical
APYX
$126M
| $816K | ﹤0.01% |
305,800
-25,000
| -8% | -$83K |
|
|
SPLP
2617
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
| $809K | ﹤0.01% |
42,161
+3,861
| +10% | +$67.7K |
|
|
USDP
2618
DELISTED
USD PARTNERS LP
USDP
| $808K | ﹤0.01% |
65,691
+6,125
| +10% | +$86.7K |
|
2619
Olin
OLN
$2.13B
| $805K | ﹤0.01% |
+24,500
| New | +$735K |
|
|
TOWR
2620
DELISTED
Tower International, Inc.
TOWR
| $805K | ﹤0.01% |
29,700
-43,881
| -60% | -$1.19M |
|
|
CIVI
2621
DELISTED
Civitas Solutions, Inc.
CIVI
| $802K | ﹤0.01% |
43,700
| – | – |
|
|
ARIS
2622
DELISTED
ARI Network Services, Inc.
ARIS
| $801K | ﹤0.01% |
154,000
-9,100
| -6% | -$47.8K |
|
|
DFRG
2623
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $800K | ﹤0.01% |
44,300
+9,175
| +26% | +$157K |
|
2624
Graphic Packaging
GPK
$3.46B
| $796K | ﹤0.01% |
61,818
-362,300
| -85% | -$4.71M |
|
|
NTP
2625
DELISTED
Nam Tai Property Inc.
NTP
| $794K | ﹤0.01% |
115,065
-74,119
| -39% | -$542K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.